George Congdon joins Morning Movers to look at an AI player in the healthcare space: Tempus AI (TEM). Shares of TEM have rallied higher after its 2Q earnings. George breaks down the latest results and the company's raised guidance. He says customers like AstraZeneca (AZN) like TEM's ability to provide data-driven insights that can potentially provide accelerated drug discovery.